THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS
Elsedeek, M., Mostafa, A., Rageh, A., Sayed Ahmed Essa, H. (2023). THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS. EKB Journal Management System, 5(4), 30-31. doi: 10.21608/alexpo.2023.246798.1728
Mervat SheikhElarab Elsedeek; Ahmed Foad Mostafa; Ahmed Shoukry Abdelmoneim Rageh; Hany Elsayed Sayed Ahmed Essa. "THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS". EKB Journal Management System, 5, 4, 2023, 30-31. doi: 10.21608/alexpo.2023.246798.1728
Elsedeek, M., Mostafa, A., Rageh, A., Sayed Ahmed Essa, H. (2023). 'THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS', EKB Journal Management System, 5(4), pp. 30-31. doi: 10.21608/alexpo.2023.246798.1728
Elsedeek, M., Mostafa, A., Rageh, A., Sayed Ahmed Essa, H. THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS. EKB Journal Management System, 2023; 5(4): 30-31. doi: 10.21608/alexpo.2023.246798.1728

THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS

ALEXMED ePosters
Article 1, Volume 5, Issue 4, December 2023, Page 30-31  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.246798.1728
View on SCiNiTO View on SCiNiTO
Authors
Mervat SheikhElarab Elsedeek1; Ahmed Foad Mostafa2; Ahmed Shoukry Abdelmoneim Rageh3; Hany Elsayed Sayed Ahmed Essa email 4
1Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Egypt.
2Department of Obstetrics and Gynecology Faculty of Medicine Alexandria University
3Department of Obstetrics and Gynecology, Alexandria Faculty of Medicine, Alexandria University
4Department of Obstetrics and Gynecology, Faculty of medicine, Alexandria university
Abstract
INTRODUCTION
Polycystic Ovary Syndrome (PCOS) is the most common condition that leads to anovulatory infertility in women. There has been a significant increase in the number of women that present with PCOS and leading to increased scientific examination towards understanding the syndrome.
The syndrome has several clinical manifestations, and anovulatory infertility is one of the most common.
Letrozole is an aromatase inhibitorhas been widely used for ovulation induction. Letrozole prevents the conversion of androgen to oestrogen by inhibiting aromatase activity. This releases the negative feedback effect of oestrogen on the hypothalamus and pituitary leading to release of gonadotrophins; causing follicular growth and subsequent ovulation. It does not have any adverse effects on the fetus and is safe.(7,8) Recently , letrozole has been suggested by ESRHE as the first line for ovulation induction in polycystic ovarian syndrome patients.
The addition of an ovulatory dose of human chorionic gonadotropin (HCG) has been used as an adjuvant to letrozole treatment to trigger ovulation.(10) When size of pre-ovulatory follicle reaches to 18-20 mm. HCG has similar activity to LH and binds to its receptor. Ovulation occurs 38-40 hours after a single HCG injection (10,000 IU IM) . The remaining parts of the dominant follicle transforms into Corpus luteum. It continues to grow during the luteal phase and produce significant amounts of hormones , particularly progesterone and to lesser extent estrogen and inhibin. Progesterone plays a vital role in making endometrial receptive to implantation of blastocyst and supportive of early pregnancy.
Keywords
GONADOTROPIN; LETROZOLE; POLYCYSTIC
Supplementary Files
Statistics
Article View: 12